Skip to content

LMA Gastro™ Airway is feasible during upper gastrointestinal interventional endoscopic procedures in high risk patients: a single-center retrospective analysis

LMA Gastro™ Airway is feasible during upper gastrointestinal interventional endoscopic procedures in high risk patients: a single-center retrospective analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00017396
Enrollment
25
Registered
2019-05-29
Start date
2019-06-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endoscopic procedures in patients ASA 3 and above

Interventions

Group 1: The retrospective data of closed files of high-risk patients undergoing elective upper gastrointestinal endoscopic procedures and interventions with the need of general anesthesia were analyz

Sponsors

Klinik für Anästhesiologie und IntensivmedizinUNIVERSITÄTSKLINIKUM FREIBURG
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria were high-risk patients undergoing elective upper gastrointestinal endoscopic procedures and interventions with the need of general anesthesia. Airway management with LMA GastroTM, ASA status 3 or above, age 10 years and older, body weight above 30 kg. Patients fasted at least for 6 hours regarding solids and at least two hours for fluids other than water. It was our intention not to exclude any patients with oesophageal reflux, oesophageal strictures, cancer of the upper gastrointestinal tract or the stomach, achalasia, pancreatitis, upper GI bleeding, colitis, pyloric stenosis, morbid obesity etc.

Exclusion criteria

Exclusion criteria: Patients below the age of 10 years

Design outcomes

Primary

MeasureTime frame
The combined outcome was defined as the feasibility to use the LMA GastroTM successfully for both, the endoscopic intervention and a sufficient airway management in the defined high-risk patients.

Secondary

MeasureTime frame
Secondary outcome parameters comprised (a) the ease to place the LMA GastroTM or any additional attempts to place the device, (b) the need of any alternative airway devices(i.e. endotracheal tube) in case of uncontrollable permanent airway leakage, (c) any form of dislocation associated to the endoscopic procedure, thus forcing the need for an alternative airway tool, other than the LMA GastroTM, (d) the incidence of pharyngeal bleeding during placement or after the removal of the LMA GastroTM, (e) any unwanted events during the endoscopic procedure with main focus on regurgitation, aspiration or hypoxia, (f) duration of the endoscopic procedure, (g) sore throat and/or hoarseness and (h) the comfort of advancing and operating the endoscope through the gastric channel rated by the attending endoscopist after the procedure via a 5 point Likert-type scale (0= not at all satisfied, 1= slightly satisfied, 2= moderately satisfied, 3= very satisfied, 4= completely satisfied).

Countries

Germany

Contacts

Public ContactAxel Schmutz

Klinik für Anästhesiologie und IntensivmedizinUNIVERSITÄTSKLINIKUM FREIBURG

axel.schmutz@uniklinik-freiburg.de0761 270 24010

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 28, 2026